Check the Batch
Class IIITerminated in FDA datasetRecall initiated Jul 26, 2018

FP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release…

Recalling firm: Confidence Inc./Confidence U.S.A. Inc.

Why it was recalled

Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol 400 and 800 (PEG), Triacetin

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Oct 22, 2019.

Check your package

Compare the exact product and package details with the label you have.

ProductFP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7
UPC810891022537

FDA code information

Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

FP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7

Extracted codes and context

TypeCode / valueContext
UPC810891022537mine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7
lot010216Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817
lot070816Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817
lot090117Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817
lot100817Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817

Original FDA recall reason

Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol 400 and 800 (PEG), Triacetin

Recall details

Recall number
F-1813-2018
Event ID
80620
FDA status
Terminated
Initiated
Jul 26, 2018
Reported
Aug 22, 2018
Classified
Aug 13, 2018
Terminated
Oct 22, 2019
Quantity
5,650 bottles in US distribution (total for all products)
Location
Port Washington, NY, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

Nationwide

FDA source record · F-1813-2018

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.